Chest
Original Research: COPDTotal and State-Specific Medical and Absenteeism Costs of COPD Among Adults Aged 18 Years in the United States for 2010 and Projections Through 2020
Section snippets
Materials and Methods
Detailed methods are described in the supplement (e-Appendix 1). The main data source for generating baseline and projected costs was the 2006 to 2010 MEPS.11 Supplemental data sources included the National Nursing Home Survey, the US Census Bureau, and the Centers for Medicare and Medicaid Services. Estimates are limited to adults aged ≥ 18 years. Because this study used public-use data sets, no subject approval was needed.
Results
The data from MEPS show that participants with COPD were older, more likely to be women, and more likely to be non-Hispanic White (Table 1). Furthermore, almost 78% of participants with COPD had one or more comorbidities, compared with about 50% of participants without COPD. In descending order, the most common comorbidities among participants with COPD were hypertension, arthritis, dyslipidemia, asthma, and injuries.
Discussion
Using the most comprehensive approach to date, we estimated that costs attributable to COPD and its sequelae were about $32.1 billion in 2010. To our knowledge, our analyses provide the first estimates of state-specific costs for state officials, public health practitioners, and other stakeholders charged with reducing the burden of COPD.
The previously reported national estimates generated by the National Heart, Lung, and Blood Institute consist of direct costs, morbidity-associated costs, and
Conclusions
Our analyses provide, we believe for the first time, state-specific costs for COPD, which equip state public health practitioners with estimates of the economic burden of COPD within their borders and illustrate the potential medical and absenteeism costs savings to states through implementing state-level programs that are designed to prevent the onset of COPD (eg, tobacco prevention and cessation). The range of evidence-based strategies to prevent COPD and decrease its effects provides
References (33)
- et al.
COPD surveillance—United States, 1999-2011
Chest
(2013) - et al.
Health economic costs of COPD in Sweden by disease severity—has it changed during a ten years period?
Respir Med
(2013) - et al.
Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy
Chest
(2001) Chronic obstructive pulmonary disease among adults—United States, 2011
MMWR Morb Mortal Wkly Rep
(2012)- et al.
Deaths: final data for 2008
Natl Vital Stat Rep
(2011) - et al.
The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Clinicoecon Outcomes Res
(2013) - et al.
Direct and indirect economic and health consequences of COPD in Denmark: a national register-based study: 1998-2010
BMJ Open
(2014) - National Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2004 Chart Book on...
Morbidity & mortality: 2007 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website
Morbidity & mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website
Morbidity & mortality: 2012 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website
Medical Expenditure Panel Survey. Agency for Healthcare Research and Quality website
State-level cancer treatment costs: how much and who pays?
Cancer
State-level estimates of cancer-related absenteeism costs
J Occup Environ Med
State-level projections of cancer-related medical care costs: 2010 to 2020
Am J Manag Care
American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association
Circulation
Cited by (297)
Best Practice Management of Patients With Chronic Obstructive Pulmonary Disease: A Case-Based Review
2022, Journal for Nurse PractitionersCitation Excerpt :COPD is also associated with a substantial and increasing economic burden.1 Total direct costs vary between countries but are largely driven by inpatient hospitalization and medication,10 with estimated costs of $32.1 billion in the US,11 and €38.6 billion in the European Union.12 Moreover, COPD and its associated comorbidities can lead to increased absenteeism or patients ceasing work owing to difficulties getting to work and worsening of symptoms that affect productivity.13
Out-of-pocket costs associated with chronic respiratory diseases in Korean adults
2024, Chronic Respiratory Disease
FUNDING/SUPPORT: This work was supported by the Centers for Disease Control and Prevention [Contract No. 200-2008-27958-0002 task order 00006].
AMERICAN COLLEGE OF CHEST PHYSICIANS. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.